Schroeder Thilo's Form 4 filing
PMV Pharmaceuticals, Inc. (PMVP) · filed Aug 20, 2021
- Accession no.
- 0001209191-21-052822
- Filed
- Aug 20, 2021
- Trade date
- Aug 18-19, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.01M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 | Common Stock | SSaleDisposed | −11,431 | $32.57 | −$372,307.67 | 1,657,040 | Indirect | |
| Aug 18, 2021 | Common Stock | SSaleDisposed | −13,196 | $33.84 | −$446,552.64 | 1,643,844 | Indirect | |
| Aug 18, 2021 | Common Stock | SSaleDisposed | −2,237 | $34.32 | −$76,773.84 | 1,641,607 | Indirect | |
| Aug 19, 2021 | Common Stock | SSaleDisposed | −3,800 | $30.97 | −$117,686 | 1,637,807 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.